71921-411-71 : NDC 2026 Code

71921-411-71 : Lacosamide Oral ( Lacosamide Oral Solution )

Additionally :

You can get information about “71921-411-71” NDC code in 71921-411-71 in HTML format

HTML | 71921-411-71 in TXT (Plain Text) format

TXT | 71921-411-71 in PDF (Portable Document Format)

PDF | 71921-411-71 in XML format

XML formats.

NDC Code : 71921-411-71 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71921-411-71",
    "PackageDescription": "1 BOTTLE in 1 CARTON (71921-411-71)  / 200 mL in 1 BOTTLE",
    "NDC11Code": "71921-0411-71",
    "ProductNDC": "71921-411",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lacosamide Oral Solution",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lacosamide Oral",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260130",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA220386",
    "LabelerName": "Florida Pharmaceutical Products, LLC",
    "SubstanceName": "LACOSAMIDE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
    "DEASchedule": "CV",
    "Status": "Active",
    "LastUpdate": "2026-02-14",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260130",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}